Gewinn- und Verlustrechnung von BioNTech

247wallst.com2026-08-21 10:06:07

Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session

The mRNA trade is whipsawing for a third straight session as the market keeps repricing a single trial readout with no fresh clinical information hitting the tape Friday.

247wallst.com2026-08-20 11:23:23

Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock are down 18% to $142.70 in Thursday midday trading, unwinding a meaningful piece of Wednesday's historic 177% rally.

globenewswire.com2026-08-20 05:30:00

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

MAINZ, Germany, August 20, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present new clinical data from its diversified development program in lung cancer treatment at the IASLC 2026 World Conference on Lung Cancer (“WCLC”) in Seoul, Republic of Korea, from September 12-15, 2026.

benzinga.com2026-08-19 12:39:16

Why Is BioNTech Stock Surging on Wednesday?

BioNTech SE (NASDAQ:BNTX) stock is trading higher on Wednesday. Investors are probably reacting to Merck & Co Inc. (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) topline data from individualized cancer therapy for advanced skin cancer.

fool.com2026-08-13 09:30:00

BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.

BioNTech has officially named its next CEO. The transition appears carefully planned, not reactive.

defenseworld.net2026-08-08 03:54:53

Bank of New York Mellon Corp Trims Stock Position in BioNTech SE Sponsored ADR $BNTX

Bank of New York Mellon Corp lowered its holdings in BioNTech SE Sponsored ADR (NASDAQ: BNTX) by 64.6% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 40,483 shares of the company's stock after selling 73,978 shares during the period. Bank of New York Mellon

seekingalpha.com2026-08-04 18:00:03

BioNTech SE (BNTX) Q2 2026 Earnings Call Transcript

marketbeat.com2026-08-04 10:06:00

BioNTech Q2 Earnings Call Highlights

BioNTech NASDAQ: BNTX reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt out of a shingles vaccine development program.

barrons.com2026-08-04 07:12:00

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Pfizer beats earnings forecasts for the second quarter, while BioNTech's results miss expectations due to weak Covid vaccine demand.

reuters.com2026-08-04 07:02:47

BioNTech lowers 2026 sales outlook as COVID vaccine demand softens

German vaccine maker BioNTech lowered its ‌full year sales outlook range on Tuesday due to softer-than-expected COVID-19 ⁠vaccine demand and the timing of milestone-related revenues.

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft

Gewinn- und Verlustrechnung von BioNTech SE

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft